mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.1 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.1 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.1 |
0.1 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.1 |